Supplementary Methods, Tables, and Figure from Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study

Autor: Lipika Goyal, Karim A. Benhadji, Yaohua He, Milind Javle, Joon Oh Park, Robin Kate Kelley, Ben Tran, Hendrik-Tobias Arkenau, John Bridgewater, Marc Sanson, Cinta Hierro, Rastislav Bahleda, Funda Meric-Bernstam
Rok vydání: 2023
DOI: 10.1158/2159-8290.22540240
Popis: Supplementary Appendix including all supplementary tables and figures
Databáze: OpenAIRE